Wasilenko S - Search Results

1

Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.

Aziz B, Kok B, Cheah M, Lytvyak E, Moctezuma-Velazquez C, Wasilenko S, Tsochatzis E, Ravikumar R, Jose S, Allison M, Gunson B, Manas D, Monaco A, Mirza D, Fusai G, Owen N, Thorburn D, Roberts K, Srinivasan P, Wigmore S, Athale A, Creamer F, Fernando B, Iyer V, Madanur M, Sen G, Montano-Loza AJ, Hansen B, Mason AL. Aziz B, et al. Among authors: wasilenko s. Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002977. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39052775

2

Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation.

Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL. Montano-Loza AJ, et al. Among authors: wasilenko s. Am J Transplant. 2010 Apr;10(4):852-858. doi: 10.1111/j.1600-6143.2009.03006.x. Epub 2010 Feb 3. Am J Transplant. 2010. PMID: 20132169 Free article.

3

Systematic review: recurrent autoimmune liver diseases after liver transplantation.

Montano-Loza AJ, Bhanji RA, Wasilenko S, Mason AL. Montano-Loza AJ, et al. Among authors: wasilenko s. Aliment Pharmacol Ther. 2017 Feb;45(4):485-500. doi: 10.1111/apt.13894. Epub 2016 Dec 12. Aliment Pharmacol Ther. 2017. PMID: 27957759 Review.

4

Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis.

Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL. Montano-Loza AJ, et al. Among authors: wasilenko s. Liver Int. 2010 Jul;30(6):871-7. doi: 10.1111/j.1478-3231.2010.02257.x. Epub 2010 May 14. Liver Int. 2010. PMID: 20492501

5

Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?

Wasilenko ST, Montano-Loza AJ, Mason AL. Wasilenko ST, et al. Viruses. 2013 Jan 24;5(2):423-38. doi: 10.3390/v5020423. Viruses. 2013. PMID: 23348060 Free PMC article. Review.

6

New insights from recurrent primary biliary cirrhosis in liver transplantation: the paradox of BEComing a fibroblast?

Wasilenko S, Mason AL. Wasilenko S, et al. Hepatology. 2007 Apr;45(4):837-40. doi: 10.1002/hep.21644. Hepatology. 2007. PMID: 17393516 No abstract available.

7

Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis.

Mason AL, Wasilenko ST. Mason AL, et al. Clin Liver Dis. 2008 May;12(2):445-60; xi. doi: 10.1016/j.cld.2008.02.006. Clin Liver Dis. 2008. PMID: 18456190 Review.

8

Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.

Sharon D, Chen M, Zhang G, Girgis S, Sis B, Graham D, McDougall C, Wasilenko ST, Montano-Loza A, Mason AL. Sharon D, et al. Among authors: wasilenko st. Liver Int. 2015 Apr;35(4):1442-50. doi: 10.1111/liv.12699. Epub 2014 Oct 31. Liver Int. 2015. PMID: 25302564 Free PMC article.

9

Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders.

McDermid J, Chen M, Li Y, Wasilenko S, Bintner J, McDougall C, Pang X, Bain VG, Mason AL. McDermid J, et al. Among authors: wasilenko s. Aliment Pharmacol Ther. 2007 Aug 15;26(4):587-95. doi: 10.1111/j.1365-2036.2007.03402.x. Aliment Pharmacol Ther. 2007. PMID: 17661762

10

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.

Mason AL, Lindor KD, Bacon BR, Vincent C, Neuberger JM, Wasilenko ST. Mason AL, et al. Among authors: wasilenko st. Aliment Pharmacol Ther. 2008 Oct 1;28(7):886-94. doi: 10.1111/j.1365-2036.2008.03799.x. Aliment Pharmacol Ther. 2008. PMID: 18627363 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters